Literature DB >> 25606366

Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases.

Zukhrofi Muzar1, Patrick E Adams2, Andrea Schneider2, Randi J Hagerman2, Reymundo Lozano2.   

Abstract

A debilitating late-onset disorder of the premutation in the FMR1 gene is the neurodegenerative disorder fragile X-associated tremor ataxia syndrome (FXTAS). We report two patients with FXTAS who have a history of substance abuse (opiates, alcohol, and cocaine) which may have exacerbated their rapid neurological deterioration with FXTAS. There has been no case report regarding the role of substance abuse in onset, progression, and severity of FXTAS symptoms. However, research has shown that substance abuse can have a negative impact on several neurodegenerative diseases, and we propose that in these cases, substance abuse contributed to a faster progression of FXTAS as well as exacerbated white matter disease.

Entities:  

Keywords:  FXTAS; Substance abuse; neurological deterioration; opiates; premutation

Year:  2014        PMID: 25606366      PMCID: PMC4298646          DOI: 10.5582/irdr.2014.01023

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  27 in total

1.  FMR1 premutation in females diagnosed with multiple sclerosis.

Authors:  L Zhang; S Coffey; L L Lua; C M Greco; J A Schafer; J Brunberg; M Borodyanskaya; M A Agius; M Apperson; M Leehey; N Tartaglia; F Tassone; P J Hagerman; R J Hagerman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-07       Impact factor: 10.154

2.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  Clinical involvement and protein expression in individuals with the FMR1 premutation.

Authors:  F Tassone; R J Hagerman; A K Taylor; J B Mills; S W Harris; L W Gane; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-03-13

4.  Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation.

Authors:  David Hessl; John M Wang; Andrea Schneider; Kami Koldewyn; Lien Le; Christine Iwahashi; Katherine Cheung; Flora Tassone; Paul J Hagerman; Susan M Rivera
Journal:  Biol Psychiatry       Date:  2011-07-23       Impact factor: 13.382

5.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

6.  Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study.

Authors:  Cary S Kogan; Jeremy Turk; Randi J Hagerman; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

7.  Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.

Authors:  Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman
Journal:  Arch Neurol       Date:  2008-08

Review 8.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

Review 9.  Hemochromatosis and alcoholic liver disease.

Authors:  Linda M Fletcher; Lawrie W Powell
Journal:  Alcohol       Date:  2003-06       Impact factor: 2.405

10.  Genomic studies in fragile X premutation carriers.

Authors:  Reymundo Lozano; Randi J Hagerman; Michael Duyzend; Dejan B Budimirovic; Evan E Eichler; Flora Tassone
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

View more
  18 in total

Review 1.  Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Authors:  Reymundo Lozano; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

Review 3.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

4.  Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.

Authors:  Igor Albizua; Benjamin L Rambo-Martin; Emily G Allen; Weiya He; Ashima S Amin; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

Review 5.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

6.  Phenobarbital use and neurological problems in FMR1 premutation carriers.

Authors:  Wilmar Saldarriaga; Pamela Lein; Laura Yuriko González Teshima; Carolina Isaza; Lina Rosa; Andrew Polyak; Randi Hagerman; Santhosh Girirajan; Marisol Silva; Flora Tassone
Journal:  Neurotoxicology       Date:  2016-01-21       Impact factor: 4.294

7.  Women with Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Andrea Schneider; Scott Summers; Flora Tassone; Andreea Seritan; David Hessl; Paul Hagerman; Randi Hagerman
Journal:  Mov Disord Clin Pract       Date:  2020-09-23

8.  Of Men and Mice: Modeling the Fragile X Syndrome.

Authors:  Regina Dahlhaus
Journal:  Front Mol Neurosci       Date:  2018-03-15       Impact factor: 5.639

9.  Increased severity of fragile X spectrum disorders in the agricultural community of Ricaurte, Colombia.

Authors:  Wilmar Saldarriaga; María J Salcedo-Arellano; Tatiana Rodriguez-Guerrero; Marcela Ríos; Andrés Fandiño-Losada; Julian Ramirez-Cheyne; Pamela J Lein; Flora Tassone; Randi J Hagerman
Journal:  Int J Dev Neurosci       Date:  2018-10-29       Impact factor: 2.457

10.  Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series.

Authors:  Maria Jimena Salcedo-Arellano; Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Yingratana A McLennan; Randi J Hagerman
Journal:  Biomedicines       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.